Study Finds Cannabis Compounds Hold Potential as Anticancer Agents
A scientific review on cancer and cannabis has concluded that various cannabinoids, including cannabidiol (CBD), cannabigerol (CBG) and delta-9 tetrahydrocannabinol (THC), hold promising potential as anticancer agents via different mechanisms. Already, clinical trials have shown the effectiveness of cannabinoids in health improvement and the regression of tumors in palliative care. The review was carried out by a team of nine scientists from schools in Turkey, Pakistan, South Korea, Romania, Portugal and Saudi Arabia. The researchers examined studies on the anticancer properties of cannabinoids, which included review articles, research papers and meta-analyzes involving in vivo, clinical and in vitro trials. Their…